期刊文献+

胸阻抗监测对腹膜透析患者心功能评价的作用 被引量:1

Role of thoracic electrical bioimpedance monitoring in the evaluation of cardiac function in peritoneal dialysis patients
原文传递
导出
摘要 目的探讨胸阻抗监测对腹膜透析(PD)患者心功能评价的作用及临床应用价值。方法对101例住院的持续非卧床腹膜透析(CAPD)患者及30例健康人(对照组)行胸阻抗法(TEB)无创血流动力学监测与心脏彩超检查,进行两组间比较及相关性分析。结果心脏彩超检查提示CAPD患者左心房内径(LAD)、左室舒张末期内径(LVDd)、左室收缩末期内径(LVDs)、室间隔厚度(IVST)、肺动脉压力(PAP)、左心室质量指数(LVMI)显著高于对照组(均P〈0.05),舒张早期和舒张晚期二尖瓣口最大血流速度之比(E/A)低于对照组(P〈0.05)。胸阻抗监测显示CAPD患者心输出量(CO)、每搏输出量(SV)、加速指数(ACI)、射血分数(EF)、速度指数(VI)显著低于对照组(均P〈0.01),收缩时间比(STR)、系统血管阻力(SVR)、胸液水平(TFC)显著高于对照组(均P〈0.01)。相关性分析显示CAPD组左心室射血分数(LVEF)与脑钠肽(BNP)呈负相关(r=-0.467,P〈0.01),LVMI与BNP呈正相关(r=0.416,P〈0.01),射血前期(PEP)、STR及TFC与BNP呈正相关(r=0.404,P〈0.01;r=0.572,P〈0.01;r=0.471,P〈0.01),EF与BNP呈负相关(r=-0.664,P〈0.01)。胸阻抗监测与心脏彩超指标之间的相关性分析显示TFC与LAD呈正相关(r=0.279,P〈0.05);PEP、STR与LVEF呈负相关(r=-0.389,P〈0.01;r=-0.446,P〈0.01),EF与LVEF呈正相关(r=0.451,P〈0.01);SV与E,A呈正相关(r=0.285,P〈0.05);SVR、TFC与LVMI呈正相关(r=0.232,P〈0.05;r=0.284,P〈0.05)。结论胸阻抗监测能评估CAPD患者心功能状态,且具有动态监测、操作简单、费用低等优点,临床上可部分代替心脏彩超进行心脏功能的评价。 Objective To evaluate the effectiveness of thoracic electrical bioimpedance(TEB) in monitoring the cardiac function of peritoneal dialysis patients. Methods One hundred and one patients with continuous ambulatory peritoneal dialysis (CAPD) and 30 healthy persons (control group) were included in the study. Thoracic electrical bioimpedance (TEB) noninvasive hemodynamic monitoring and echocardiography were taken to analyze the correlation between indexes. Results Echocardiography showed that left atrial diameter (LAD), left Ventricular end diastolic diameter (LVDd), left ventricular end systolic diameter (LVDs), interventricular septal thickness (IVST), interventricular septal thickness (PAP), left ventricle weight index (LVMI) of CAPD group were higher than that of the control group (all P 〈 0.05), early and late wave of mitral valve flow (E/A) of CAPD group was lower than that of control group (P 〈 0.05). TEB monitoring showed that cardiac output (CO), stroke volume (SV), acceleration index (ACI), ejection fraction (EF),velocity index (VI) of CAPD group were significantly lower than that of control group (all P 〈 0.01), systolic time ratio (STR), SVR, TFC of CAPD group were significantly higher than that of control group (P 〈 0.01). Correlation analysis show that left ventricular ejection fraction (LVEF) was negatively correlated with BNP (r = -0.467, P 〈 0.01), LVMI was positively correlated with BNP (r = 0.416, P 〈 0.01), PEP, STR and TFC were positively correlated with BNP (r = 0.404, P 〈 0.01; r = 0.572, P 〈 0.01; r = 0.471, P 〈 0.01), EF was negatively correlated with BNP (r =-0.664, P 〈 0.01). Correlation analysis between echocardiography and TEB monitoring index showed there was significant correlation between EF and LVEF (r = 0.451, P 〈 0.01), SVR and TFC were positively correlated with LVMI (r = 0.232, P 〈 0.05; r = 0.284, P 〈 0.05), SV was positively correlated with E/A (r = 0.285, P 〈 0.05), pre-ejection period (PEP) and STR were negatively correlated with LVEF (r =-0.389, P 〈 0.01; r =-0.446, P 〈 0.01), TFC was positively correlated with LAD (r= 0.279, P〈 0.05). Conclusion TEB monitoring can accurately evaluate the cardiac function with the advantage of dynamic monitoring and simple operation. It can partly replace the echocardiography test.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第9期655-659,共5页 Chinese Journal of Nephrology
关键词 腹膜透析 超声心动描记术 多普勒 彩色 心功能 胸阻抗 Peritoneal dialysis Echocardiography, Doppler, color Cardiac function Thoracic electrical bioimpedance
  • 相关文献

参考文献16

  • 1Kendrick J, Teitelbaum I, Strategies for improving long- term survival in peritoneal dialysis patients. Clin J Am Soc Nephrol,2010, 5: 1123-1131.
  • 2Bandschapp O, Goff R, Mallin G, et al. The path of a pulmonary artery catheter visualized through a beating human heart. Am J Respir Crit Care Med, 2012, 186: 385.
  • 3Fukuda Y, Soeki T, Sata M. A novel Doppler echocardiographic index integrating left and right ventricular function is superior to conventional indices for predicting adverse outcome of acute myocardial infarction. J Med Invest, 2013, 60: 97-105.
  • 4Tokarik M, Sjtiberg F, Balik M, et al. Fluid therapy LiDCO controlled trial- optimization of volume resuscitation of extensively burned patients through noninvasive continuous real -time hemodynamic monitoring LiDCO. J Burn Care Res, 2013, 34: 537-542.
  • 5胡大一,杨振华.B型钠尿肽的临床应用和最新进展.北京:科学技术出版社,2006:11.
  • 6王兰兰,蔡蓓,刘兴斌,刘瑾,黄德嘉,唐江涛,李立新.N末端脑型钠尿肽定量检测在心力衰竭诊断中的价值[J].中华检验医学杂志,2006,29(1):35-38. 被引量:50
  • 7McCullough PA, Sandberg KR. B- type natriuretic peptide and renal disease. Heart Fail Rev, 2003, 8: 355-358.
  • 8张桂红,任野平,纪天蓉,宋晓辉,孔凡武.腹膜透析对尿毒症患者心脏结构与功能改变的影响[J].中国中西医结合肾病杂志,2011,12(3):251-253. 被引量:8
  • 9Foley R, levey A, Samak M. cardiovascular disease in chronic Dis, 1998, 32: 112-119. Clinical epideminology of renal failure. Am J Kidney.
  • 10Tz H, Ozkahya M, Dorhout Mees EJ. Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int, 1999, 56: 350- 351.

二级参考文献19

  • 1林雪,朱文玲,方理刚.脑钠肽在心力衰竭和心肌梗死中的临床意义[J].中华心血管病杂志,2004,32(5):469-471. 被引量:47
  • 2毛拥军,张春华,刘松,陈祥鸿.脑钠肽与充血性心力衰竭的治疗[J].中华心血管病杂志,2004,32(9):855-857. 被引量:47
  • 3Prontera C, Emdin M, Zucchelli GC, et al. Analytical performance and diagnostic accuracy of a fully automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. Clin Chem Lab Med ,2004,42:37-44.
  • 4Berendes E, Schmidt C, Van Aken H, et al. A-type and B-type natriuretic peptides in cardiac surgical procedures. Anesth Analg,2004, 98:11-19.
  • 5Mair J, Hammerer-Lereher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med ,2001,39 :571-588.
  • 6Mueller T, Gegenhuber A, Poelz W, et al. Biochemical diagnosis of impaired left ventricular ejection fraction-comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP). Clin Chem Lab Med, 2004,42:159-163.
  • 7Fujimoto N, Iseki K, Tokuyama K, et al. Significance of coronary artery calcification score(CACS) for the detection of coronary artery disease in chronic dialysis patients. Clin Chim Acta, 2006, 367(1 -2) :98 - 102.
  • 8Pozzoni P, Del Vecchio L, Pontoriero G, et al. Long - teim out- come in hemodialysis : morbidity and mortality. J Nephrol, 2004, 17 ( Suppl 8 ) : S87 - S95.
  • 9Foley RN, Parfrey PS, Hamett JD, et al. The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol, 1995,5(12) :2024 - 2031.
  • 10Nayak SG, Satisk R, Gokulnath. An unusual toxic cause of hemo lyticuremic syndrome. J Toxicol Sci, 2007,32 ( 2 ) : 197 - 199.

共引文献112

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部